Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected1Y Return
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | MRNA | AMGN | GILD |
|---|---|---|---|
| Return | |||
| Last Price | — | 437.32 | 150.70 |
| Daily Change | — | − 1.53% | − 0.34% |
| Period ReturnPast Year | + 504.71% | + 52.28% | + 33.63% |
| Valuation | |||
| Market Cap | $57.8 B | $236 B | $187 B |
| P/E Ratio | — | 27.16 | — |
| Dividend Yield | — | 3.21% | 3.98% |
| Net MarginTrailing 12M | 141.4% | 23.0% | 10.6% |
| Risk | |||
| Beta | 1.22 | 0.45 | 0.40 |
| 52-Week Range | 22.28 — $176.66 | 269.77 — $447.03 | 108.46 — $157.29 |
| Company | |||
| Sector | Health Care | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology | Biotechnology |
Company
- MRNAHealth Care · Biotechnology
- AMGNHealth Care · Biotechnology
- GILDHealth Care · Biotechnology
FinnhubUpdated 21:53
To Understand This